Skip to content Skip to footer

Project Name: AdvanCore by AS – Innovation to the bone
Project Code: POCI-07-62H2-FEDER-181357
Main Objectivel: Strengthen the competitiveness of small and medium enterprises
Intervention Region: North
Beneficiary Entity: Artur Salgado, S.A.

Approval date | 01/06/2022
Start Date | 20/08/2022
Conclusion Date | 30-06-2023
Total eligible cost | 912.337,75 €
Financial support from the European Union | 277.228,84 €

Objectives, activities and expected/achieved results

The investments contemplated in the project are intended to promote the creation of products for medical use with high added value. The objectives to be achieved are the following:

  • Promote the creation of value and boost a more comprehensive and specialized offer, always from a perspective of continuous improvement and compliance with the legal and regulatory requirements applicable to its activity and products;
  • Establishing itself in new markets that value high added-value products;
  • Potentiate internationalisation by taking advantage of the synergies provided by long-lasting commercial relations with its suppliers, achieving an export rate of more than 10% in the year after the project;
  • To reach profitability levels that guarantee the sustained growth of the company;
  • To reach a turnover greater than 7.000.000€ in the year after the project, of which 14% refers to production activity.


Go to Top